CFO Joshua Smiley On Lilly’s Next Decade Of Growth

Strategy Includes Product-Specific Deals In $1bn Range

 
• By Mandy Jackson
  
Growing bars graphic with rising arrow
Lilly expects to deliver "top-tier" growth through 2025 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip